Compare Dow Inc (DOW) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs HCA Health Inc — how do they compare? Dow Inc trades at $28.42 (market cap $20.65B), while HCA Health Inc trades at $451.09 (market cap $96.35B). The key difference: HCA Health Inc is far larger — about 4.7× Dow Inc's market cap, and Dow Inc pays the higher dividend (4.9%). Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 82 Days and HCA Health Inc for 76 Days on average.
| DOW | HCA | |
|---|---|---|
Market Cap | $20.65B | $96.35B |
Volume | 14,126,943 | 1,079,453 |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $545.13 |
52-Week Low | $20.65 | $361.32 |
Typical Hold Time | 82 Days | 76 Days |
Enterprise Value | $36.34B | $146.88B |
Dividend Yield | 4.9% | 0.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.59, up 2.95% today, near the analyst low target of $28.00. The stock shows a bullish technical signal despite mixed indicators, with recent earnings beats in Q4 2025 through Q2 2026. However, fundamentals are weak, with a negative net income margin of -3.13% in 2025 and declining revenue from $56.9B in 2022 to $40.0B in 2025. Cash flow trends improved in 2025, but debt-to-asset ratios have risen to 29.87%.
The outlook is cautious; while analyst consensus is a buy with a $34.22 target, high valuation (P/E 75.93) and profitability challenges pose risks. Opportunities include dividend stability and potential margin recovery, but investors face headwinds from cyclical demand and competitive pressures in the chemicals sector.
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
